NEW YORK, Aug. 8, 2024 /PRNewswire/ -- Mason Capital
Management LLC, a Delaware limited
liability company ("Mason Capital"), announced today the expiration
and settlement of its previously announced tender offer (the
"Tender Offer") for any and all the outstanding American depositary
shares (the "ADSs") and ordinary shares (the "Ordinary Shares") in
Forward Pharma A/S for a purchase price of $437.00 per ADS or 0.76
DKK per Ordinary Share, the terms and conditions of which
are described in an Offer to Purchase, dated May 14, 2024, a related Letter of Transmittal,
dated May 14, 2024 and a related
Share Transfer Note, dated May 14,
2024 (together, the "Tender Offer Materials").
The Tender Offer expired as scheduled at 5:00 p.m., New York
City time, on July 31, 2024
(the "Expiration Date") and all 1,344 ADSs validly tendered into
the Tender Offer prior to the Expiration Date were accepted and
settled on August 1, 2024.
MacKenzie Partners is the information and tender agent for the
Tender Offer. Requests for additional copies of the Tender Offer
Materials may be directed to MacKenzie Partners at 800-322-2885 or
tenderoffer@mackenziepartners.com.
This press release does not constitute an offer to purchase
securities or a solicitation of an offer to sell any securities or
an offer to sell or the solicitation of an offer to purchase any
new securities, nor does it constitute an offer or solicitation in
any jurisdiction in which such offer or solicitation is unlawful.
Capitalized terms used in this press release but not otherwise
defined herein have the meanings assigned to them in the Tender
Offer Materials.
About Mason Capital
Mason Capital is a global event driven hedge fund founded in
July 2000 by Ken Garschina and Mike
Martino. Assets under management are $1.37 billion as of December 31, 2023. Mason Capital has an absolute
return focus and seeks to generate consistent positive returns in
any market environment.
Forward-Looking Statements
This press release contains forward-looking statements.
Forward-looking statements are information of a non-historical
nature or which relate to future events and are subject to risks
and uncertainties. No assurance can be given that the transactions
described herein will be consummated or as to the ultimate terms of
any such transactions. Mason Capital undertakes no obligation to
publicly update or revise any forward-looking statements, whether
as a result of new information or future events or for any other
reason.
View original
content:https://www.prnewswire.co.uk/news-releases/mason-capital-announces-expiration-and-settlement-of-its-tender-offer-302218415.html